Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Epitopes | 5 | 2021 | 2503 | 1.180 |
Why?
|
Antigens, Neoplasm | 12 | 2022 | 1993 | 1.110 |
Why?
|
Peptides | 19 | 2022 | 4358 | 1.040 |
Why?
|
Histocompatibility Antigens Class I | 6 | 2022 | 1349 | 0.920 |
Why?
|
Cancer Vaccines | 8 | 2024 | 1051 | 0.890 |
Why?
|
Polyomavirus Infections | 2 | 2023 | 194 | 0.880 |
Why?
|
Influenza A virus | 3 | 2015 | 458 | 0.770 |
Why?
|
Carcinoma, Merkel Cell | 2 | 2023 | 328 | 0.750 |
Why?
|
Epitopes, T-Lymphocyte | 12 | 2021 | 828 | 0.670 |
Why?
|
CD8-Positive T-Lymphocytes | 11 | 2024 | 4580 | 0.660 |
Why?
|
Databases, Protein | 2 | 2019 | 387 | 0.610 |
Why?
|
Pemphigus | 5 | 2011 | 107 | 0.540 |
Why?
|
T-Lymphocytes | 18 | 2021 | 10194 | 0.510 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 8 | 2020 | 822 | 0.510 |
Why?
|
Proteome | 3 | 2021 | 1862 | 0.440 |
Why?
|
Receptors, Antigen, T-Cell | 8 | 2021 | 2547 | 0.370 |
Why?
|
Lung | 4 | 2023 | 10000 | 0.340 |
Why?
|
Indoleamine-Pyrrole 2,3,-Dioxygenase | 7 | 2006 | 117 | 0.330 |
Why?
|
Skin Neoplasms | 4 | 2023 | 5821 | 0.320 |
Why?
|
HLA Antigens | 9 | 2022 | 1328 | 0.310 |
Why?
|
T-Cell Antigen Receptor Specificity | 2 | 2018 | 85 | 0.300 |
Why?
|
Immunotherapy | 7 | 2021 | 4652 | 0.300 |
Why?
|
Immunoglobulins, Intravenous | 3 | 2010 | 664 | 0.290 |
Why?
|
Receptors, IgG | 2 | 2008 | 559 | 0.280 |
Why?
|
Single-Cell Analysis | 4 | 2023 | 2449 | 0.280 |
Why?
|
Decidua | 1 | 2007 | 82 | 0.280 |
Why?
|
Melanoma | 7 | 2022 | 5709 | 0.270 |
Why?
|
Killer Cells, Natural | 4 | 2023 | 2200 | 0.270 |
Why?
|
Myelin Proteolipid Protein | 3 | 2018 | 107 | 0.260 |
Why?
|
T-Lymphocytes, Cytotoxic | 5 | 2024 | 1784 | 0.250 |
Why?
|
Nitrates | 1 | 2006 | 263 | 0.250 |
Why?
|
Cytokines | 7 | 2023 | 7396 | 0.240 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 4 | 2020 | 1640 | 0.230 |
Why?
|
Chemokines | 2 | 2024 | 960 | 0.220 |
Why?
|
Multiple Sclerosis | 4 | 2020 | 3220 | 0.220 |
Why?
|
Minor Histocompatibility Antigens | 2 | 2018 | 293 | 0.220 |
Why?
|
Tryptophan Oxygenase | 5 | 2003 | 19 | 0.220 |
Why?
|
Glioblastoma | 1 | 2018 | 3482 | 0.220 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2007 | 629 | 0.210 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 2 | 2017 | 800 | 0.210 |
Why?
|
Lymphocyte Activation | 9 | 2021 | 5486 | 0.200 |
Why?
|
Dexamethasone | 2 | 2020 | 1948 | 0.200 |
Why?
|
Oligodeoxyribonucleotides | 1 | 2024 | 779 | 0.200 |
Why?
|
Antigens, Viral, Tumor | 1 | 2022 | 153 | 0.200 |
Why?
|
Dendritic Cells | 6 | 2024 | 2747 | 0.190 |
Why?
|
Influenza A Virus, H1N1 Subtype | 2 | 2017 | 445 | 0.180 |
Why?
|
Lymphocyte Transfusion | 1 | 2021 | 232 | 0.180 |
Why?
|
Genes, MHC Class II | 2 | 2012 | 434 | 0.180 |
Why?
|
Leukocytes, Mononuclear | 2 | 2023 | 1844 | 0.180 |
Why?
|
Immunologic Memory | 4 | 2021 | 1359 | 0.180 |
Why?
|
Antigen Presentation | 5 | 2021 | 1251 | 0.180 |
Why?
|
Viruses | 2 | 2022 | 375 | 0.180 |
Why?
|
Cell Line | 12 | 2023 | 15601 | 0.180 |
Why?
|
Tumor Virus Infections | 1 | 2023 | 438 | 0.170 |
Why?
|
Neoplasms | 11 | 2023 | 22170 | 0.170 |
Why?
|
Amino Acid Motifs | 2 | 2019 | 931 | 0.170 |
Why?
|
Immune Tolerance | 4 | 2018 | 2303 | 0.160 |
Why?
|
Pemphigoid, Bullous | 2 | 2010 | 112 | 0.160 |
Why?
|
Neuromyelitis Optica | 1 | 2022 | 263 | 0.160 |
Why?
|
Chromatography, Liquid | 3 | 2021 | 983 | 0.160 |
Why?
|
DNA Modification Methylases | 1 | 2018 | 210 | 0.150 |
Why?
|
Open Reading Frames | 1 | 2021 | 815 | 0.150 |
Why?
|
Immunity | 1 | 2023 | 996 | 0.150 |
Why?
|
Humans | 66 | 2024 | 761504 | 0.150 |
Why?
|
Substrate Specificity | 1 | 2021 | 1791 | 0.140 |
Why?
|
Mass Spectrometry | 5 | 2022 | 2192 | 0.140 |
Why?
|
DNA Repair Enzymes | 1 | 2018 | 346 | 0.140 |
Why?
|
Epigenesis, Genetic | 2 | 2022 | 3802 | 0.140 |
Why?
|
Alleles | 5 | 2021 | 6863 | 0.140 |
Why?
|
Peptide Hydrolases | 1 | 2019 | 624 | 0.140 |
Why?
|
Tandem Mass Spectrometry | 3 | 2021 | 1188 | 0.130 |
Why?
|
Amino Acid Sequence | 11 | 2021 | 13446 | 0.130 |
Why?
|
Peptide Fragments | 4 | 2018 | 5112 | 0.130 |
Why?
|
HLA-A Antigens | 3 | 2010 | 223 | 0.130 |
Why?
|
Neuroblastoma | 1 | 2024 | 1250 | 0.130 |
Why?
|
Cell Differentiation | 4 | 2017 | 11528 | 0.130 |
Why?
|
Tumor Escape | 1 | 2018 | 370 | 0.130 |
Why?
|
Macrophages | 4 | 2021 | 5769 | 0.120 |
Why?
|
High-Throughput Screening Assays | 1 | 2020 | 934 | 0.120 |
Why?
|
Mice | 25 | 2024 | 81525 | 0.120 |
Why?
|
Lectins, C-Type | 1 | 2018 | 585 | 0.120 |
Why?
|
Ligands | 2 | 2019 | 3272 | 0.110 |
Why?
|
Algorithms | 6 | 2019 | 14031 | 0.110 |
Why?
|
Leukemia | 1 | 2021 | 1522 | 0.110 |
Why?
|
Sequence Analysis, RNA | 2 | 2019 | 2020 | 0.110 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2019 | 1320 | 0.110 |
Why?
|
Gene Expression Profiling | 6 | 2023 | 9420 | 0.110 |
Why?
|
Multiple Myeloma | 2 | 2024 | 5146 | 0.110 |
Why?
|
HLA-A2 Antigen | 2 | 2010 | 211 | 0.110 |
Why?
|
Stem Cell Transplantation | 1 | 2021 | 1600 | 0.110 |
Why?
|
Blastomeres | 1 | 2012 | 29 | 0.110 |
Why?
|
Immunoconjugates | 1 | 2020 | 954 | 0.110 |
Why?
|
CD4-Positive T-Lymphocytes | 3 | 2022 | 4369 | 0.110 |
Why?
|
Antigens, CD | 4 | 2018 | 4003 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2019 | 1405 | 0.100 |
Why?
|
Phosphoglycerate Kinase | 1 | 2012 | 66 | 0.100 |
Why?
|
Proteomics | 2 | 2023 | 3849 | 0.100 |
Why?
|
Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2012 | 78 | 0.100 |
Why?
|
beta Karyopherins | 1 | 2012 | 46 | 0.100 |
Why?
|
Animals | 30 | 2024 | 168459 | 0.100 |
Why?
|
Cyclophilin A | 1 | 2012 | 58 | 0.100 |
Why?
|
Vaccination | 4 | 2024 | 3384 | 0.100 |
Why?
|
Cell Line, Tumor | 8 | 2024 | 16981 | 0.100 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2024 | 1860 | 0.100 |
Why?
|
Tryptophan | 3 | 2003 | 482 | 0.100 |
Why?
|
Major Histocompatibility Complex | 1 | 2015 | 870 | 0.100 |
Why?
|
Tumor Microenvironment | 5 | 2024 | 3877 | 0.100 |
Why?
|
Genes, MHC Class I | 1 | 2012 | 235 | 0.100 |
Why?
|
Immunotherapy, Adoptive | 1 | 2021 | 1469 | 0.100 |
Why?
|
Biopsy | 1 | 2023 | 6766 | 0.100 |
Why?
|
Keratinocytes | 2 | 2012 | 790 | 0.090 |
Why?
|
Neoadjuvant Therapy | 1 | 2022 | 2827 | 0.090 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2024 | 8547 | 0.090 |
Why?
|
Adoptive Transfer | 5 | 2018 | 819 | 0.090 |
Why?
|
Skin Diseases, Vesiculobullous | 1 | 2011 | 85 | 0.090 |
Why?
|
RNA, Messenger | 3 | 2019 | 12795 | 0.090 |
Why?
|
Antibodies, Monoclonal | 4 | 2018 | 9177 | 0.090 |
Why?
|
Immunosuppressive Agents | 2 | 2015 | 4174 | 0.090 |
Why?
|
Genetic Loci | 1 | 2019 | 2632 | 0.090 |
Why?
|
Polymerase Chain Reaction | 1 | 2019 | 6075 | 0.090 |
Why?
|
Pemphigoid, Benign Mucous Membrane | 1 | 2010 | 113 | 0.090 |
Why?
|
Allergy and Immunology | 1 | 2011 | 176 | 0.080 |
Why?
|
Germ-Line Mutation | 1 | 2018 | 1858 | 0.080 |
Why?
|
Sulfonamides | 1 | 2019 | 1978 | 0.080 |
Why?
|
Polyglycolic Acid | 1 | 2011 | 406 | 0.080 |
Why?
|
T-Lymphocyte Subsets | 1 | 2017 | 1802 | 0.080 |
Why?
|
Graft vs Host Disease | 2 | 2020 | 3029 | 0.080 |
Why?
|
Software | 4 | 2023 | 4434 | 0.080 |
Why?
|
Data Mining | 1 | 2014 | 551 | 0.080 |
Why?
|
Protein Multimerization | 1 | 2014 | 983 | 0.080 |
Why?
|
Chromosomes, Human, Y | 1 | 2010 | 161 | 0.080 |
Why?
|
rap1 GTP-Binding Proteins | 1 | 2008 | 51 | 0.080 |
Why?
|
Histocompatibility | 1 | 2010 | 317 | 0.080 |
Why?
|
Microarray Analysis | 2 | 2009 | 749 | 0.080 |
Why?
|
Receptors, Cell Surface | 1 | 2018 | 2822 | 0.080 |
Why?
|
Tumor Suppressor Proteins | 1 | 2018 | 2803 | 0.080 |
Why?
|
Human papillomavirus 16 | 1 | 2010 | 267 | 0.080 |
Why?
|
Interferon-gamma | 3 | 2012 | 3162 | 0.080 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2023 | 4026 | 0.080 |
Why?
|
Virulence Factors | 1 | 2011 | 513 | 0.070 |
Why?
|
Lod Score | 1 | 2008 | 600 | 0.070 |
Why?
|
Autoimmune Diseases | 2 | 2011 | 2244 | 0.070 |
Why?
|
Candida | 1 | 2009 | 172 | 0.070 |
Why?
|
Papillomaviridae | 1 | 2014 | 1119 | 0.070 |
Why?
|
Papillomavirus Vaccines | 1 | 2014 | 496 | 0.070 |
Why?
|
Embryonic Development | 1 | 2012 | 721 | 0.070 |
Why?
|
Knowledge Bases | 2 | 2021 | 97 | 0.070 |
Why?
|
DNA Methylation | 2 | 2018 | 4398 | 0.070 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2012 | 686 | 0.070 |
Why?
|
Viral Proteins | 2 | 2011 | 1804 | 0.070 |
Why?
|
Promoter Regions, Genetic | 1 | 2018 | 5789 | 0.070 |
Why?
|
Protein Carbonylation | 1 | 2006 | 28 | 0.070 |
Why?
|
Databases, Genetic | 1 | 2014 | 1742 | 0.070 |
Why?
|
Mice, Transgenic | 6 | 2023 | 9539 | 0.070 |
Why?
|
Cells, Cultured | 6 | 2019 | 18965 | 0.070 |
Why?
|
Stem Cell Factor | 1 | 2007 | 195 | 0.070 |
Why?
|
Transcription Factors | 3 | 2023 | 12128 | 0.070 |
Why?
|
Genes | 1 | 2010 | 1823 | 0.070 |
Why?
|
Autoantigens | 1 | 2010 | 891 | 0.070 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2010 | 547 | 0.070 |
Why?
|
Interleukin-15 | 1 | 2007 | 185 | 0.070 |
Why?
|
Mitochondria | 1 | 2019 | 3624 | 0.070 |
Why?
|
Macrophages, Alveolar | 1 | 2008 | 412 | 0.070 |
Why?
|
Tumor Cells, Cultured | 3 | 2022 | 6132 | 0.060 |
Why?
|
Antibody Formation | 1 | 2010 | 1395 | 0.060 |
Why?
|
Latent Tuberculosis | 1 | 2009 | 224 | 0.060 |
Why?
|
Carcinoma, Renal Cell | 1 | 2021 | 3164 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2021 | 9280 | 0.060 |
Why?
|
Lactic Acid | 1 | 2011 | 1139 | 0.060 |
Why?
|
Transfection | 4 | 2007 | 5774 | 0.060 |
Why?
|
Superoxides | 1 | 2006 | 387 | 0.060 |
Why?
|
Ovarian Neoplasms | 1 | 2022 | 4876 | 0.060 |
Why?
|
Transplantation, Homologous | 3 | 2021 | 4806 | 0.060 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 2 | 2021 | 1092 | 0.060 |
Why?
|
Jurkat Cells | 2 | 2018 | 740 | 0.060 |
Why?
|
Interleukin-10 | 2 | 2008 | 1175 | 0.060 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 5315 | 0.060 |
Why?
|
Proteins | 2 | 2011 | 6032 | 0.060 |
Why?
|
Antigen-Presenting Cells | 3 | 2022 | 964 | 0.060 |
Why?
|
Drug Delivery Systems | 1 | 2015 | 2226 | 0.060 |
Why?
|
Kidney Neoplasms | 1 | 2021 | 4249 | 0.060 |
Why?
|
Computational Biology | 3 | 2010 | 3518 | 0.060 |
Why?
|
Gene Targeting | 1 | 2007 | 838 | 0.060 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2020 | 5671 | 0.060 |
Why?
|
Molecular Sequence Data | 6 | 2014 | 17635 | 0.050 |
Why?
|
Cloning, Molecular | 2 | 2019 | 4174 | 0.050 |
Why?
|
Genetic Linkage | 1 | 2008 | 2341 | 0.050 |
Why?
|
Vaccines, Subunit | 1 | 2023 | 161 | 0.050 |
Why?
|
B-Cell Maturation Antigen | 1 | 2024 | 149 | 0.050 |
Why?
|
Epithelial Cells | 1 | 2015 | 3673 | 0.050 |
Why?
|
Phagocytosis | 1 | 2008 | 1528 | 0.050 |
Why?
|
Vaccines, DNA | 1 | 2024 | 286 | 0.050 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2022 | 11742 | 0.050 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2009 | 832 | 0.050 |
Why?
|
Interleukin-18 | 1 | 2023 | 250 | 0.050 |
Why?
|
Oxygenases | 1 | 2002 | 59 | 0.050 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2006 | 1171 | 0.050 |
Why?
|
Amino Acids | 1 | 2008 | 1718 | 0.050 |
Why?
|
Autoantibodies | 1 | 2010 | 2116 | 0.050 |
Why?
|
Chemical Fractionation | 1 | 2021 | 61 | 0.050 |
Why?
|
Aquaporin 4 | 1 | 2022 | 161 | 0.050 |
Why?
|
Phenotype | 5 | 2022 | 16591 | 0.050 |
Why?
|
Stromal Cells | 1 | 2007 | 1330 | 0.050 |
Why?
|
Sequence Analysis, DNA | 1 | 2012 | 4740 | 0.050 |
Why?
|
Intracellular Signaling Peptides and Proteins | 3 | 2023 | 2872 | 0.050 |
Why?
|
Antineoplastic Agents | 1 | 2024 | 13639 | 0.050 |
Why?
|
Mice, Inbred C57BL | 6 | 2024 | 22169 | 0.050 |
Why?
|
B-Lymphocytes | 2 | 2011 | 4758 | 0.050 |
Why?
|
HEK293 Cells | 2 | 2021 | 4278 | 0.040 |
Why?
|
Influenza, Human | 1 | 2011 | 1521 | 0.040 |
Why?
|
Protein Binding | 4 | 2017 | 9351 | 0.040 |
Why?
|
Maternal-Fetal Exchange | 1 | 2002 | 461 | 0.040 |
Why?
|
Graft vs Leukemia Effect | 1 | 2020 | 121 | 0.040 |
Why?
|
Quantitative Trait Loci | 1 | 2008 | 2116 | 0.040 |
Why?
|
Oligopeptides | 1 | 2005 | 1187 | 0.040 |
Why?
|
Prostaglandins | 1 | 2001 | 398 | 0.040 |
Why?
|
Female | 18 | 2024 | 392644 | 0.040 |
Why?
|
Desmoglein 3 | 2 | 2010 | 9 | 0.040 |
Why?
|
Potassium Channels | 1 | 2022 | 537 | 0.040 |
Why?
|
Ribonuclease H | 1 | 2019 | 50 | 0.040 |
Why?
|
Dioxygenases | 1 | 2002 | 345 | 0.040 |
Why?
|
CpG Islands | 1 | 2024 | 1230 | 0.040 |
Why?
|
Nanoparticles | 1 | 2011 | 1959 | 0.040 |
Why?
|
Histocompatibility Antigens Class II | 2 | 2017 | 1435 | 0.040 |
Why?
|
DNA, Complementary | 2 | 2012 | 1991 | 0.040 |
Why?
|
Antirheumatic Agents | 1 | 2008 | 1372 | 0.040 |
Why?
|
Liposomes | 2 | 2015 | 784 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2023 | 13380 | 0.040 |
Why?
|
Melanoma-Specific Antigens | 1 | 2018 | 74 | 0.040 |
Why?
|
Down-Regulation | 2 | 2002 | 2919 | 0.040 |
Why?
|
Cell Adhesion | 2 | 2002 | 3087 | 0.040 |
Why?
|
Interleukin-1beta | 1 | 2023 | 999 | 0.040 |
Why?
|
Mycobacterium tuberculosis | 1 | 2009 | 1914 | 0.040 |
Why?
|
Mice, Inbred BALB C | 1 | 2006 | 6216 | 0.040 |
Why?
|
Endothelial Cells | 1 | 2010 | 3548 | 0.040 |
Why?
|
Oxidative Phosphorylation | 1 | 2019 | 496 | 0.040 |
Why?
|
Automation | 1 | 2020 | 586 | 0.040 |
Why?
|
Integrin alpha Chains | 1 | 2017 | 95 | 0.040 |
Why?
|
Gene Expression Regulation | 3 | 2023 | 11903 | 0.030 |
Why?
|
Microglia | 1 | 2005 | 1361 | 0.030 |
Why?
|
Artificial Intelligence | 1 | 2011 | 2578 | 0.030 |
Why?
|
Cell Communication | 1 | 2023 | 1657 | 0.030 |
Why?
|
Middle Aged | 7 | 2019 | 220895 | 0.030 |
Why?
|
Haplotypes | 1 | 2022 | 2713 | 0.030 |
Why?
|
Genomics | 2 | 2023 | 5821 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2023 | 1626 | 0.030 |
Why?
|
Adaptive Immunity | 1 | 2020 | 726 | 0.030 |
Why?
|
Young Adult | 3 | 2018 | 59243 | 0.030 |
Why?
|
HLA-DR2 Antigen | 2 | 2005 | 44 | 0.030 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2023 | 1606 | 0.030 |
Why?
|
Mice, Inbred Strains | 2 | 2010 | 1762 | 0.030 |
Why?
|
Orthomyxoviridae Infections | 1 | 2017 | 254 | 0.030 |
Why?
|
Paclitaxel | 1 | 2022 | 1732 | 0.030 |
Why?
|
Recombinant Fusion Proteins | 2 | 2015 | 3734 | 0.030 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2017 | 452 | 0.030 |
Why?
|
Optical Tweezers | 1 | 2015 | 85 | 0.030 |
Why?
|
Hematopoietic Stem Cells | 1 | 2007 | 3396 | 0.030 |
Why?
|
Models, Molecular | 2 | 2015 | 5439 | 0.030 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2008 | 3080 | 0.030 |
Why?
|
Cell Separation | 2 | 2011 | 1720 | 0.030 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2023 | 2425 | 0.030 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2023 | 2825 | 0.030 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2017 | 1351 | 0.030 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2022 | 3514 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2011 | 3810 | 0.030 |
Why?
|
Aged | 5 | 2019 | 169289 | 0.030 |
Why?
|
Kinetics | 1 | 2021 | 6374 | 0.030 |
Why?
|
Mutation | 2 | 2017 | 30052 | 0.030 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2017 | 3639 | 0.030 |
Why?
|
Mass Screening | 1 | 2008 | 5428 | 0.030 |
Why?
|
Male | 11 | 2021 | 360804 | 0.030 |
Why?
|
Cell Cycle Proteins | 1 | 2023 | 3448 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2023 | 3466 | 0.020 |
Why?
|
Disulfides | 1 | 2014 | 465 | 0.020 |
Why?
|
Spleen | 1 | 2018 | 2295 | 0.020 |
Why?
|
Lymphocyte Culture Test, Mixed | 2 | 2002 | 509 | 0.020 |
Why?
|
Tissue Donors | 1 | 2021 | 2331 | 0.020 |
Why?
|
Adult | 5 | 2019 | 221177 | 0.020 |
Why?
|
Coculture Techniques | 2 | 2008 | 1341 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2019 | 5305 | 0.020 |
Why?
|
Desmoglein 1 | 1 | 2010 | 7 | 0.020 |
Why?
|
Non-Fibrillar Collagens | 1 | 2010 | 25 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2019 | 3602 | 0.020 |
Why?
|
Integrin alpha6 | 1 | 2010 | 30 | 0.020 |
Why?
|
Integrin beta4 | 1 | 2010 | 31 | 0.020 |
Why?
|
Conserved Sequence | 1 | 2014 | 1163 | 0.020 |
Why?
|
Protein Subunits | 1 | 2014 | 943 | 0.020 |
Why?
|
Flow Cytometry | 2 | 2011 | 5869 | 0.020 |
Why?
|
Nanostructures | 1 | 2015 | 553 | 0.020 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2015 | 2748 | 0.020 |
Why?
|
Epitope Mapping | 1 | 2011 | 298 | 0.020 |
Why?
|
Papillomavirus E7 Proteins | 1 | 2010 | 109 | 0.020 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2017 | 1651 | 0.020 |
Why?
|
Fusion Proteins, bcr-abl | 1 | 2012 | 431 | 0.020 |
Why?
|
HLA-DQ Antigens | 1 | 2010 | 191 | 0.020 |
Why?
|
DNA | 1 | 2024 | 7212 | 0.020 |
Why?
|
Autophagy | 1 | 2018 | 1326 | 0.020 |
Why?
|
Antigens, Viral | 1 | 2014 | 988 | 0.020 |
Why?
|
Luminescent Proteins | 1 | 2012 | 837 | 0.020 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2012 | 330 | 0.020 |
Why?
|
Transforming Growth Factor beta | 1 | 2017 | 1961 | 0.020 |
Why?
|
Cytoplasm | 1 | 2014 | 1510 | 0.020 |
Why?
|
Cell Lineage | 2 | 2012 | 2555 | 0.020 |
Why?
|
Consumer Product Safety | 1 | 2010 | 122 | 0.020 |
Why?
|
Tuberculin | 1 | 2009 | 64 | 0.020 |
Why?
|
Guanine Nucleotide-Releasing Factor 2 | 1 | 2008 | 5 | 0.020 |
Why?
|
Mechanotransduction, Cellular | 1 | 2014 | 529 | 0.020 |
Why?
|
Immunologic Capping | 1 | 2008 | 30 | 0.020 |
Why?
|
Azathioprine | 1 | 2010 | 354 | 0.020 |
Why?
|
Academies and Institutes | 1 | 2011 | 318 | 0.020 |
Why?
|
HLA-DR Antigens | 1 | 2010 | 602 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2023 | 5796 | 0.020 |
Why?
|
Drug Compounding | 1 | 2010 | 246 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2008 | 15936 | 0.020 |
Why?
|
Janus Kinase 3 | 1 | 2009 | 76 | 0.020 |
Why?
|
Drug Contamination | 1 | 2010 | 152 | 0.020 |
Why?
|
Oncogene Proteins, Viral | 1 | 2010 | 340 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2020 | 3065 | 0.020 |
Why?
|
U937 Cells | 1 | 2008 | 261 | 0.020 |
Why?
|
Energy Metabolism | 1 | 2019 | 2882 | 0.020 |
Why?
|
Cell Proliferation | 3 | 2009 | 10445 | 0.020 |
Why?
|
Tuberculin Test | 1 | 2009 | 206 | 0.020 |
Why?
|
Sequence Alignment | 1 | 2012 | 2180 | 0.020 |
Why?
|
DNA Primers | 1 | 2012 | 2819 | 0.020 |
Why?
|
Second Messenger Systems | 1 | 2008 | 202 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2014 | 2231 | 0.020 |
Why?
|
Plasma Cells | 1 | 2011 | 599 | 0.020 |
Why?
|
Recombination, Genetic | 1 | 2012 | 1519 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2010 | 878 | 0.020 |
Why?
|
Cyclosporine | 1 | 2010 | 778 | 0.020 |
Why?
|
Bystander Effect | 1 | 2008 | 90 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2019 | 64680 | 0.020 |
Why?
|
Antibodies | 1 | 2015 | 2418 | 0.020 |
Why?
|
Pregnancy | 2 | 2007 | 29874 | 0.020 |
Why?
|
Transduction, Genetic | 1 | 2010 | 903 | 0.020 |
Why?
|
Prognosis | 1 | 2008 | 29625 | 0.020 |
Why?
|
Signal Transduction | 3 | 2023 | 23445 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2014 | 3792 | 0.020 |
Why?
|
Apoptosis | 2 | 2019 | 9486 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2023 | 5671 | 0.020 |
Why?
|
Benzamides | 1 | 2012 | 1370 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2008 | 17904 | 0.020 |
Why?
|
Bronchi | 1 | 2010 | 845 | 0.020 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2010 | 790 | 0.020 |
Why?
|
Antigens, Surface | 1 | 2010 | 1606 | 0.020 |
Why?
|
Candidiasis | 1 | 2009 | 365 | 0.020 |
Why?
|
Up-Regulation | 2 | 2007 | 4124 | 0.020 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2009 | 687 | 0.020 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2008 | 694 | 0.020 |
Why?
|
Product Surveillance, Postmarketing | 1 | 2010 | 452 | 0.020 |
Why?
|
Organ Specificity | 1 | 2010 | 1967 | 0.020 |
Why?
|
Patient Compliance | 1 | 2015 | 2690 | 0.020 |
Why?
|
Antigens | 1 | 2011 | 1443 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2021 | 14605 | 0.020 |
Why?
|
Probability | 1 | 2010 | 2477 | 0.020 |
Why?
|
Isoantigens | 1 | 2007 | 551 | 0.020 |
Why?
|
Virulence | 1 | 2009 | 1303 | 0.020 |
Why?
|
Cytoskeletal Proteins | 1 | 2010 | 1342 | 0.020 |
Why?
|
Disease | 1 | 2010 | 672 | 0.010 |
Why?
|
Cyclophosphamide | 1 | 2010 | 2218 | 0.010 |
Why?
|
Cell Membrane | 1 | 2014 | 3688 | 0.010 |
Why?
|
Cyclic AMP | 1 | 2008 | 1463 | 0.010 |
Why?
|
Interleukin-17 | 1 | 2010 | 912 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 4575 | 0.010 |
Why?
|
Mice, Knockout | 2 | 2011 | 14414 | 0.010 |
Why?
|
Antigens, Bacterial | 1 | 2009 | 1155 | 0.010 |
Why?
|
Receptors, Interleukin-3 | 1 | 2002 | 29 | 0.010 |
Why?
|
Neovascularization, Physiologic | 1 | 2010 | 1349 | 0.010 |
Why?
|
Interleukin-3 Receptor alpha Subunit | 1 | 2002 | 36 | 0.010 |
Why?
|
Disease Progression | 1 | 2019 | 13506 | 0.010 |
Why?
|
Thymus Gland | 1 | 2007 | 1243 | 0.010 |
Why?
|
Receptors, CCR6 | 1 | 2002 | 74 | 0.010 |
Why?
|
Cattle | 1 | 2008 | 3849 | 0.010 |
Why?
|
Enzyme Inhibitors | 2 | 2002 | 3712 | 0.010 |
Why?
|
Piperazines | 1 | 2012 | 2523 | 0.010 |
Why?
|
Receptors, Immunologic | 1 | 2008 | 1410 | 0.010 |
Why?
|
Drug Approval | 1 | 2008 | 814 | 0.010 |
Why?
|
Mice, Inbred CBA | 1 | 2002 | 436 | 0.010 |
Why?
|
Binding Sites | 1 | 2010 | 6055 | 0.010 |
Why?
|
Base Sequence | 1 | 2012 | 12441 | 0.010 |
Why?
|
Risk Factors | 1 | 2008 | 74206 | 0.010 |
Why?
|
Lymphoid Tissue | 1 | 2002 | 445 | 0.010 |
Why?
|
RNA, Antisense | 1 | 2001 | 136 | 0.010 |
Why?
|
Forkhead Transcription Factors | 1 | 2008 | 1616 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2019 | 58976 | 0.010 |
Why?
|
Models, Immunological | 1 | 2003 | 513 | 0.010 |
Why?
|
Interleukin-2 | 1 | 2007 | 1889 | 0.010 |
Why?
|
Transplantation Immunology | 1 | 2002 | 532 | 0.010 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2001 | 318 | 0.010 |
Why?
|
United States Food and Drug Administration | 1 | 2008 | 1664 | 0.010 |
Why?
|
Pyrimidines | 1 | 2012 | 3028 | 0.010 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 2002 | 899 | 0.010 |
Why?
|
Drug Design | 1 | 2005 | 1048 | 0.010 |
Why?
|
Gene Expression | 1 | 2012 | 7581 | 0.010 |
Why?
|
Receptors, Chemokine | 1 | 2002 | 652 | 0.010 |
Why?
|
Metalloendopeptidases | 1 | 2001 | 393 | 0.010 |
Why?
|
Repressor Proteins | 1 | 2010 | 2986 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2007 | 3778 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2022 | 80636 | 0.010 |
Why?
|
Genetic Variation | 1 | 2014 | 6567 | 0.010 |
Why?
|
Boston | 1 | 2011 | 9326 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2010 | 4414 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2011 | 11076 | 0.010 |
Why?
|
Genotype | 1 | 2012 | 12990 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2010 | 4936 | 0.010 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2002 | 974 | 0.010 |
Why?
|
Databases, Factual | 1 | 2011 | 7967 | 0.010 |
Why?
|
Calcium | 1 | 2008 | 5722 | 0.010 |
Why?
|
Skin | 1 | 2008 | 4484 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2012 | 20098 | 0.010 |
Why?
|
MicroRNAs | 1 | 2010 | 3816 | 0.010 |
Why?
|
Cell Division | 1 | 2001 | 4465 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2009 | 12974 | 0.010 |
Why?
|
Inflammation | 2 | 2003 | 10773 | 0.010 |
Why?
|
Rats | 1 | 2008 | 23742 | 0.010 |
Why?
|
United States | 1 | 2008 | 72334 | 0.000 |
Why?
|